Autophagy and Cancer Therapy (original) (raw)
Rapid CommunicationMinireview
Molecular Pharmacology June 2014, 85 (6) 830-838; DOI: https://doi.org/10.1124/mol.114.091850
Abstract
Autophagy is the process by which cellular material is delivered to lysosomes for degradation and recycling. There are three different types of autophagy, but macroautophagy, which involves the formation of double membrane vesicles that engulf proteins and organelles that fuse with lysosomes, is by far the most studied and is thought to have important context-dependent roles in cancer development, progression, and treatment. The roles of autophagy in cancer treatment are complicated by two important discoveries over the past few years. First, most (perhaps all) anticancer drugs, as well as ionizing radiation, affect autophagy. In most, but not all cases, these treatments increase autophagy in tumor cells. Second, autophagy affects the ability of tumor cells to die after drug treatment, but the effect of autophagy may be to promote or inhibit cell death, depending on context. Here we discuss recent research related to autophagy and cancer therapy with a focus on how these processes may be manipulated to improve cancer therapy.
Footnotes
Received January 15, 2014.
Accepted February 26, 2014.
This work was supported by grants from the National Institutes of Health National Cancer Institute [Grants R01-CA111421, R01-CA150925, and P30-CA046934].
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.